![Lannett Shares Jolted By FDA Approval Of Cocaine Spray For Nasal Surgery]( "Lannett Shares Jolted By FDA Approval Of Cocaine Spray For Nasal Surgery")
Pharmaceutical products manufacturer Lannett Company, Inc. (NYSE: LCI) said Monday that its New Drug Application for cocaine hydrochloride nasal solution under the brand name Numbrino has received FDA approval. “The FDA’s approval of our Cocaine HCl product, the first NDA approval to include full clinical trials in the company’s history, marks a major milestone in Lannett’s 70+ years of operations,” CEO Tim Crew said in a statement. Numbrino nasal solution is an ester local anesthetic indicated for the introduction of local anesthesia of the mucous membranes for conducting surgeries or diagnostic operations through the nasal cavities of adults.
